0001995074-26-000003.txt : 20260702 0001995074-26-000003.hdr.sgml : 20260702 20260702121738 ACCESSION NUMBER: 0001995074-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260702 DATE AS OF CHANGE: 20260702 EFFECTIVENESS DATE: 20260702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NurExone Biologic Inc. CENTRAL INDEX KEY: 0001995074 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-589452 FILM NUMBER: 261149118 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: MINUS 1 ENTRY, GROUND FLOOR OF BLDG B STREET 2: GUTWIRTH INDUSTRIAL PARK CITY: TECHNION CITY, HAIFA PROVINCE COUNTRY: L3 BUSINESS PHONE: 972 52-4803034 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: MINUS 1 ENTRY, GROUND FLOOR OF BLDG B STREET 2: GUTWIRTH INDUSTRIAL PARK CITY: TECHNION CITY, HAIFA PROVINCE COUNTRY: L3 D 1 primary_doc.xml X0708 D LIVE 0001995074 NurExone Biologic Inc. MINUS 1 ENTRY, GROUND FLOOR OF BLDG B GUTWIRTH INDUSTRIAL PARK TECHNION CITY, HAIFA L3 ISRAEL 3200003 972 52-4803034 ONTARIO, CANADA WALMER CAPITAL CORP. ENERSPAR CORP. None Corporation true 2025 Lior Shaltiel Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Director Eran Ovadya Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Yoram Drucker Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Director Oded Orgil Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director James Richardson Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director Eyal Gabbai Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director Biotechnology Decline to Disclose 06b false 2026-06-30 false true true true false 0 441779 441779 0 CDN$627,795.26. Based on the Bank of Canada exchange rate of 0.7037 on June 30, 2026. Consists of the issuance of 1,012,573 units. false 2 0 0 0 false NurExone Biologic Inc. /s/ Eran Ovadya Eran Ovadya Chief Financial Officer 2026-07-01